Richardson-based MedeAnalytics, an enterprise healthcare performance company delivering AI-driven data, analytics, and SaaS solutions, has appointed Chris Lance as its new chief product officer.
Lance brings more than 20 years of experience leading enterprise product and technology organizations, MedeAnalytics said, with a proven track record of building scalable platforms and high-performing portfolios that deliver measurable value for payers and providers.
As chief product officer, he will lead MedeAnalytics’ product vision, strategy, and execution across its Enterprise Healthcare Performance Cloud.
“I’m excited to join MedeAnalytics at what I believe is a true inflection point for healthcare,” Lance said in a statement. “By connecting trusted data with advanced analytics, AI, and intelligent workflows, MedeAnalytics is uniquely positioned to help organizations manage complexity, move faster, and achieve better outcomes.”
“I look forward to working with the team to build products that turn data into intelligence, intelligence into action, and action into measurable healthcare performance across the ecosystem,” he added.
Oversaw products at Avalon Healthcare Solutions
Prior to joining MedeAnalytics, Lance served as chief product officer at Avalon Healthcare Solutions, where he built high-performing teams, shaped enterprise and product strategy, and delivered innovative laboratory benefit management solutions. He also played a key leadership role in Avalon’s sale to WindRose Health Investors, MedeAnalytics said.
Before Avalon, Lance was chief product officer at Edifecs, where he led a portfolio of market-leading products. During his tenure, he spearheaded the company’s transition to a cloud-first SaaS business model and, in partnership with the CEO and CFO, facilitated a successful multi-billion-dollar sale of the company to Cotiviti.
Earlier in his career, Lance served as chief product officer at Evolent Health, leading the development and delivery of the organization’s health plan administration software and services portfolios. Prior to that, he rose through increasingly senior leadership roles at Change Healthcare, ultimately serving as Head of Product for a broad suite of payer financial management solutions, including Payment Integrity, Clinical Editing, Risk Adjustment, and Value-Based Payments. In these roles, he led multiple business transformation initiatives, including the adoption of platform-based operating models.
Lance began his career outside of healthcare, holding leadership roles across management consulting, general management, product management, sales, and engineering in the manufacturing and brewing industries, MedeAnalytics said—adding that his diverse background has shaped his perspective “on product leadership, customer value creation, and organizational transformation.” He holds an MBA from the Olin School of Business at Washington University in St. Louis and a bachelor’s degree in industrial engineering from Purdue University.
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
-
Justin Neece comes to Richardson-based MedeAnalytics following his recent role as chief growth officer at Azara Healthcare, which merged with i2i Population Healthcare, for which he had served as president and CEO.
-
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
-
Motivus, a global technology, data and AI consulting firm with an office in Irving, announced earlier this month that it added two executives to its leadership team as the company pursues new markets and ambitious growth. Kevin Walmsley was named chief financial and operations officer, and Navneet Narula became chief sales officer. Motivus said both bring decades of experience to help advance its strategic vision and deliver digital innovation for clients. The company, which rebranded from AgileThought in October 2024, says the new identity reflects its shift toward higher-value offerings in software development and technology consulting. The new hires come…
-
The Dallas firm’s new product and marketing execs—former Epsilon leader Wayne Townsend and two-time martech CMO Natalie Cunningham—are tasked with helping marketers cut through AI noise, data silos, and rising personalization demands.
-
Caroline Carney, a board-certified internist and board-certified psychiatrist, has held key clinical leadership positions serving complex populations over the span of her career, including a post as medical director for the Indiana Office of Medicaid Policy and Planning.
